AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2010
Jan 11, 2010
29745_dirs_2010-01-11_0114ac25-383a-4600-9a2e-768a49741f72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-01-01
Reporting Person: Tapiero Jacques (SVP&Pres.-Emerging Markets BU)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6212 | Direct |
| Common Stock | 10590 | Indirect |
| Common Stock | 1591 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option 10/01 (right to buy) | $79.28 | 2011-10-04 | Common Stock (5000) | Direct | |
| Employee stock option 2/01 (right to buy) | $73.98 | 2011-02-18 | Common Stock (12000) | Direct | |
| Employee stock option 2/02 (right to buy) | $75.92 | 2012-02-17 | Common Stock (14000) | Direct | |
| Employee stock option 2/03 (right to buy) | $57.85 | 2013-02-15 | Common Stock (11000) | Direct | |
| Employee stock option 2/04 (right to buy) | $73.11 | 2015-02-16 | Common Stock (14000) | Direct | |
| Employee stock option 2/05 (right to buy) | $55.65 | 2015-02-10 | Common Stock (21302) | Direct | |
| Employee stock option 2/06 (right to buy) | $56.18 | 2016-02-09 | Common Stock (19578) | Direct | |
| Resticted Stock Unit | $ | 2012-10-01 | Common Stock (12500) | Direct | |
| Restricted Stock Unit | $ | 2011-10-01 | Common Stock (12500) | Direct |
Footnotes
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29